Patents by Inventor Martin H. Bluth

Martin H. Bluth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230277651
    Abstract: Techniques for inhibiting viral disease are provided. The techniques include obtaining a blood product from a convalescent patient, and administering the blood product to a patient at risk of contracting the same type of virus in order to propagate immunoglobulin-based vaccination.
    Type: Application
    Filed: July 26, 2021
    Publication date: September 7, 2023
    Inventor: Martin H. Bluth
  • Patent number: 8012928
    Abstract: A method of treating pancreatitis is provided, including the steps of: providing a mammal having pancreatitis; and administering a therapeutically effective amount of a truncated N-terminal PAP2; and making of an antibody specifically directed to detect PAP2.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: September 6, 2011
    Assignee: The Research Foundation of State University of New York
    Inventors: Martin H. Bluth, Michael Zenilman
  • Publication number: 20100158809
    Abstract: A method of treating pancreatitis is provided, including the steps of: providing a mammal having pancreatitis; and administering a therapeutically effective amount of a truncated N-terminal PAP2; and making of an antibody specifically directed to detect PAP2.
    Type: Application
    Filed: December 18, 2009
    Publication date: June 24, 2010
    Applicant: The Research Foundation of State University of New York
    Inventors: Martin H. Bluth, Michael Zenilman
  • Publication number: 20100099615
    Abstract: The present invention provides a method of treating diabetes, including administering to a mammal diagnosed with diabetes a purified recombinant reg I protein.
    Type: Application
    Filed: October 15, 2009
    Publication date: April 22, 2010
    Applicant: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
    Inventors: Martin H. Bluth, Michael Zenilman
  • Patent number: 7649113
    Abstract: The present invention is directed to novel compounds which are derivatives of minocycline or doxycycline, pharmaceutical compositions containing same and use thereof in lowering excess IgE levels in a mammal suffering from a disease where IgE is pathogenic.
    Type: Grant
    Filed: August 25, 2008
    Date of Patent: January 19, 2010
    Assignee: The Research Foundation of State University of New York
    Inventors: Helen G. Durkin, Martin H. Bluth, Tamar A. Smith-Norowitz, Rauno Joks, Alexander Kiselyov
  • Patent number: 7604801
    Abstract: The present invention provides a method for diagnosing a subject suffering a pathological condition characterized by parvovirus infection by detecting the presence of IgE anti-Parvovirus B 19 antibodies.
    Type: Grant
    Filed: October 16, 2008
    Date of Patent: October 20, 2009
    Assignee: The Research Foundation of State University of New York
    Inventors: Tamar Smith-Norowitz, Kevin D. Norowitz, Martin H. Bluth, Helen G. Durkin
  • Publication number: 20090186835
    Abstract: A method and composition for the prophylaxis or treatment of humans or animals for cancer using a mixture of sophorolipids.
    Type: Application
    Filed: January 14, 2009
    Publication date: July 23, 2009
    Inventors: Richard A. Gross, Martin H. Bluth
  • Publication number: 20090041781
    Abstract: The present invention provides a method for diagnosing a subject suffering a pathological condition characterized by parvovirus infection by detecting the presence of IgE anti-Parvovirus B 19 antibodies.
    Type: Application
    Filed: October 16, 2008
    Publication date: February 12, 2009
    Applicant: The Research Foundation of State University of New York
    Inventors: Tamar Smith-Norowitz, Kevin D. Norowitz, Martin H. Bluth, Helen G. Durkin
  • Publication number: 20080312470
    Abstract: The present invention is directed to novel compounds which are derivatives of minocycline or doxycycline, pharmaceutical compositions containing same and use thereof in lowering excess IgE levels in a mammal suffering from a disease where IgE is pathogenic.
    Type: Application
    Filed: August 25, 2008
    Publication date: December 18, 2008
    Applicant: The Research Foundation of State University of New York
    Inventors: Helen G. Durkin, Martin H. Bluth, Tamar A. Smith-Norowitz, Rauno Joks, Alexander Kiselyov
  • Patent number: 7445889
    Abstract: The present invention provides a method for diagnosing a subject suffering a pathological condition characterized by parvovirus infection by detecting the presence of IgE anti-Parvovirus B 19 antibodies.
    Type: Grant
    Filed: May 5, 2004
    Date of Patent: November 4, 2008
    Assignee: The Research Foundation of State University of New York
    Inventors: Tamar Smith-Norowitz, Kevin D. Norowitz, Martin H. Bluth, Helen G. Durkin
  • Patent number: 7425655
    Abstract: The present invention is directed novel compounds which are derivatives of minocycline or doxycycline, pharmaceutical compositions containing same and use thereof in lowering excess IgE levels in a mammal suffering from a disease where IgE is pathogenic.
    Type: Grant
    Filed: February 9, 2004
    Date of Patent: September 16, 2008
    Assignee: The Research Foundation of State University of New York
    Inventors: Helen G. Durkin, Martin H. Bluth, Tamar A. Smith-Norowitz, Rauno Joks, Alexander Kiselyov